Intramyocardial Dissecting Hematoma: A Mechanical Complication Needing Surgical Therapy?
Mauro Rossi Prat1, Maximiliano de Abreu1, Graciela Reyes2
1Cardiology Department, Hospital El Cruce, Buenos Aires, Argentina.
JACC. Case Reports
|November 17, 2022
Insights
Intramyocardial dissecting hematoma, a cardiac rupture complication, presents a management challenge. This case series explores treatment strategies for this rare cardiac condition.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Research
Background:
- Intramyocardial dissecting hematoma is a rare cardiac complication.
- It arises from partial rupture of the ventricular wall, often due to myocardial infarction, percutaneous coronary intervention, or trauma.
- Current therapeutic management and optimal surgical timing remain unstandardized.
Observation:
- This study presents a case series of 4 patients diagnosed with intramyocardial dissecting hematoma.
- The cases highlight the varied clinical presentations and etiologies of this condition.
- Detailed patient data and diagnostic imaging findings were reviewed.
Findings:
- The case series provides insights into the clinical course and outcomes of patients with intramyocardial dissecting hematoma.
- Treatment approaches varied across the 4 patients, reflecting the lack of standardized protocols.
- Outcomes were assessed in relation to the interventions performed.
Implications:
- The findings underscore the need for further research into standardized diagnostic and therapeutic guidelines for intramyocardial dissecting hematoma.
- Understanding the management of this condition can improve patient outcomes in cardiovascular medicine.
- This case series contributes to the limited existing literature on intramyocardial dissecting hematoma, aiding future clinical decision-making.
Abstract:
Intramyocardial dissecting hematoma is a form of cardiac rupture caused by myocardial infarction, percutaneous coronary intervention, or trauma. It is a cavity between myocardial fibers caused by partial rupture of the ventricular wall. Therapeutic management, including the timing for surgical approach, has not been standardized. We present a case series describing 4 patients. (Level of Difficulty: Intermediate.).
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
01:29Cardiomyopathy V: Interprofessional Care
27
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
01:30Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
01:17Pericarditis III: Medical Management
22
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
22
01:21Myocarditis I: Introduction
21
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
21
01:14Myocarditis III: Medical Management
13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13